Johannes Jacob Pieter Kastelein, Chief Scientific Officer: NewAmsterdam Pharma NAMS Planned sale · Filed 02/20

Trade details

Type: Planned sale notice
Stock: NewAmsterdam Pharma NAMS
Person: Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale date: 26/02/20
Filed: 26/02/20

More to sell after $199.5K in 3 months

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 01/21~03/22

Johannes Jacob Pieter Kastelein's recent trades

Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.5M
125,000 sh
$3.5M
Filed 08/24
Traded 08/24
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.2M
104,467 sh
$3.2M
Filed 03/09
Traded 03/05
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.1M
101,409 sh
$3.1M
Filed 03/09
Traded 03/09
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$2.9M
94,124 sh
$2.9M
Filed 03/09
Traded 03/06
Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$9.4M
300,000 sh
$9.4M
Filed 03/05
Traded 03/02

Johannes Jacob Pieter Kastelein, Chief Officer — plans to sell 45,481 sh of NewAmsterdam Pharma NAMS · $1.6M · around 02/20 | Whalegun